Home / APNHY : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does APNHY make money? Does APNHY have pricing power? What's the Earnings Whisper? Will APNHY profit more as the business scales? What is APNHY's management track record? Is APNHY's current price justified?

Aspen Pharmacare Holdings Limited

$9.72 +$3.14 (+47.72%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

$9.73

Day Range

$9.64$9.72

Year Range

$5.24$9.73

Market Cap

4.32B

AVG Volume

195

Trailing/Forward PE

26.49/0.9

PEG ratio

4.16

Dividend Yield

1.34%

Next Earnings Date

2027-03-11

Primary Exchange

Other OTC

Revenue (ZAR)

APNHY Revenue (ZAR) by quarter
Period	Revenue (ZAR)
26 Q4	18.4B
26 Q2	16.27B
25 Q4	21.4B
25 Q2	21.96B
24 Q4	23.57B
24 Q2	21.14B
23 Q4	21.56B
23 Q2	19.15B
22 Q4	19.23B
22 Q2	19.38B

Net Income (ZAR)

APNHY Net Income (ZAR) by quarter
Period	Net Income (ZAR)
26 Q4	1.21B
26 Q2	1.4B
25 Q4	-3.47B
25 Q2	2.39B
24 Q4	2.09B
24 Q2	2.31B
23 Q4	2.55B
23 Q2	2.67B
22 Q4	3.13B
22 Q2	3.36B

Operating Income (ZAR)

APNHY Operating Income (ZAR) by quarter
Period	Operating Income (ZAR)
26 Q4	2.37B
26 Q2	2.96B
25 Q4	3.05B
25 Q2	11M
24 Q4	3.5B
24 Q2	3.5B
23 Q4	5.16B
23 Q2	4.34B
22 Q4	4.38B
22 Q2	4.84B

EBITDA (ZAR)

APNHY EBITDA (ZAR) by quarter
Period	EBITDA (ZAR)
26 Q4	3.36B
26 Q2	3.87B
25 Q4	-2.26B
25 Q2	4.93B
24 Q4	5.86B
24 Q2	4.44B
23 Q4	5.43B
23 Q2	4.76B
22 Q4	5.05B
22 Q2	5.41B

Cash Flows (ZAR)

APNHY Cash Flows (ZAR) by quarter
Period	Cash Flows (ZAR)
26 Q4	2.5B
26 Q2	2.33B
25 Q4	1.98B
25 Q2	608M
24 Q4	2.14B
24 Q2	966M
23 Q4	1.75B
23 Q2	587M
22 Q4	2.05B
22 Q2	631M

EPS (ZAR)

APNHY EPS (ZAR) by quarter
Period	EPS (ZAR)
26 Q4	2.72
26 Q2	3.15
25 Q4	-7.82
25 Q2	5.38
24 Q4	4.71
24 Q2	5.21
23 Q4	5.75
23 Q2	6.02
22 Q4	6.94
22 Q2	7.36

Expenses (ZAR)

APNHY Expenses (ZAR) by quarter
Period	Expenses (ZAR)
26 Q4	5.57B
26 Q2	5.21B
25 Q4	7B
25 Q2	6.57B
24 Q4	6.89B
24 Q2	6.49B
23 Q4	6.97B
23 Q2	5.74B
22 Q4	6.04B
22 Q2	5.42B

Cash & Debt (ZAR)

APNHY Cash & Debt (ZAR) by quarter
Period	Cash & Debt (ZAR)
26 Q4	15.87B
26 Q2	5.61B
25 Q4	6.41B
25 Q2	6.8B
24 Q4	12.34B
24 Q2	11.6B
23 Q4	10.91B
23 Q2	8.04B
22 Q4	6.18B
22 Q2	7.88B

Debt ratios

APNHY Debt ratios by quarter
Period	Debt ratios
26 Q4	-0.04
26 Q2	2.2
25 Q4	2.29
25 Q2	1.39
24 Q4	1.18
24 Q2	1.25
23 Q4	0.89
23 Q2	0.99
22 Q4	0.86
22 Q2	1.09

Margins

APNHY Margins by quarter
Period	Margins
26 Q4	37.11%
26 Q2	43.64%
25 Q4	40.53%
25 Q2	47.6%
24 Q4	42.88%
24 Q2	44.05%
23 Q4	46.24%
23 Q2	46.82%
22 Q4	44.92%
22 Q2	47.08%

Return on Capital

APNHY Return on Capital by quarter
Period	Return on Capital
26 Q4	1.52%
26 Q2	1.73%
25 Q4	-4.09%
25 Q2	2.81%
24 Q4	2.46%
24 Q2	2.7%
23 Q4	2.96%
23 Q2	3.56%
22 Q4	4.41%
22 Q2	4.67%

Shares Outstanding

APNHY Shares Outstanding by quarter
Period	Shares Outstanding
26 Q4	443.59M
26 Q2	444.6M
25 Q4	444.1M
25 Q2	444.1M
24 Q4	444.12M
24 Q2	444.32M
23 Q4	444.24M
23 Q2	444.2M
22 Q4	450.7M
22 Q2	456.5M

Dividends (ZAR)

APNHY Dividends (ZAR) by quarter
Period	Dividends (ZAR)
Oct 26	0.14
Oct 25	0.12
Sep 24	0.21
Sep 23	0.18
Sep 22	0.18
Sep 21	0.17
Oct 18	0.21
Oct 17	0.21
Oct 16	0.17
Oct 15	0.16

Book Value Per Share (ZAR)

APNHY Book Value Per Share (ZAR) by quarter
Period	Book Value Per Share (ZAR)
26 Q4	179.74
26 Q2	182.2
25 Q4	191.16
25 Q2	191.59
24 Q4	191.07
24 Q2	192.66
23 Q4	194.12
23 Q2	169.32
22 Q4	157.4
22 Q2	157.64

Total Assets (ZAR)

APNHY Total Assets (ZAR) by quarter
Period	Total Assets (ZAR)
26 Q4	107.41B
26 Q2	127.92B
25 Q4	135.89B
25 Q2	136.6B
24 Q4	139.16B
24 Q2	139.29B
23 Q4	134.28B
23 Q2	120.58B
22 Q4	111.38B
22 Q2	117.34B

PE Ratio

APNHY PE Ratio by quarter
Period	PE Ratio
Sep 26	28.91
Sep 26	27.14
Aug 26	26.24
Aug 26	25.99
Aug 26	28.11
Aug 26	28
Jul 26	27.1
Jul 26	28.14
Jul 26	27.53
Jul 26	27.04
Jul 26	28.21
Jun 26	27.96
Jun 26	26.41
Jun 26	26.15
Jun 26	27.02
May 26	26.27
May 26	24.72
May 26	27.14
May 26	26.62
May 26	24.67
Apr 26	25.83
Apr 26	24.07
Apr 26	25.13
Apr 26	23.81
Mar 26	17.44
Mar 26	17.95
Mar 26	17.88
Mar 26	18.63
Feb 26	17.82
Feb 26	17.12
Feb 26	16.52
Feb 26	14.45
Jan 26	14.59
Jan 26	15
Jan 26	16.12
Jan 26	15.64
Jan 26	14.51
Dec 25	12.49
Dec 25	12.74
Dec 25	12.51
Dec 25	12.56
Nov 25	12.31
Nov 25	12.33
Nov 25	12.63
Nov 25	13.02
Oct 25	12.76
Oct 25	13.33
Oct 25	13.41
Oct 25	13.33
Oct 25	12.94
Sep 25	4.49
Sep 25	4.78
Sep 25	5.02
Sep 25	4.95
Aug 25	5.04
Aug 25	4.92
Aug 25	5.32
Aug 25	5.21
Aug 25	5.47
Jul 25	5.62
Jul 25	5.38
Jul 25	5.5
Jul 25	5.81
Jun 25	5.66
Jun 25	5.69
Jun 25	5.66
Jun 25	5.8
May 25	5.84
May 25	5.58
May 25	5.63
May 25	5.83
May 25	5.9
Apr 25	5.66
Apr 25	7.54
Apr 25	6.99
Apr 25	6.97
Mar 25	7.65
Mar 25	8.33
Mar 25	8.22
Mar 25	8.11
Feb 25	7.84
Feb 25	7.89
Feb 25	7.85
Feb 25	7.79
Jan 25	7.8
Jan 25	7.68
Jan 25	7.57
Jan 25	8.15
Jan 25	7.11
Dec 24	8.06
Dec 24	7.9
Dec 24	7.74
Dec 24	7.81
Nov 24	7.76
Nov 24	8.04
Nov 24	7.92
Nov 24	8.19
Nov 24	8.52
Oct 24	8.11
Oct 24	8.63

Free Cash Flow Yield

APNHY Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	10.13%
Sep 26	10.8%
Aug 26	11.17%
Aug 26	11.27%
Aug 26	10.42%
Aug 26	10.46%
Jul 26	10.81%
Jul 26	10.41%
Jul 26	10.64%
Jul 26	10.84%
Jul 26	10.38%
Jun 26	10.48%
Jun 26	11.09%
Jun 26	11.2%
Jun 26	10.84%
May 26	11.15%
May 26	11.85%
May 26	10.79%
May 26	11.01%
May 26	11.88%
Apr 26	11.34%
Apr 26	12.17%
Apr 26	11.66%
Apr 26	12.3%
Mar 26	9.83%
Mar 26	9.55%
Mar 26	9.58%
Mar 26	9.2%
Feb 26	9.62%
Feb 26	10.01%
Feb 26	10.38%
Feb 26	11.86%
Jan 26	11.74%
Jan 26	11.42%
Jan 26	10.63%
Jan 26	10.96%
Jan 26	11.81%
Dec 25	13.72%
Dec 25	13.45%
Dec 25	13.7%
Dec 25	13.65%
Nov 25	13.93%
Nov 25	13.89%
Nov 25	13.57%
Nov 25	13.16%
Oct 25	13.43%
Oct 25	12.85%
Oct 25	12.77%
Oct 25	12.85%
Oct 25	13.24%
Sep 25	13.04%
Sep 25	12.23%
Sep 25	11.66%
Sep 25	11.82%
Aug 25	11.61%
Aug 25	11.89%
Aug 25	10.99%
Aug 25	11.23%
Aug 25	10.71%
Jul 25	10.41%
Jul 25	10.87%
Jul 25	10.63%
Jul 25	10.07%
Jun 25	10.34%
Jun 25	10.29%
Jun 25	10.34%
Jun 25	10.09%
May 25	10.01%
May 25	10.48%
May 25	10.39%
May 25	10.03%
May 25	9.92%
Apr 25	10.34%
Apr 25	7.76%
Apr 25	8.37%
Apr 25	8.39%
Mar 25	7.4%
Mar 25	6.79%
Mar 25	6.88%
Mar 25	6.98%
Feb 25	7.21%
Feb 25	7.17%
Feb 25	7.2%
Feb 25	7.26%
Jan 25	7.25%
Jan 25	7.36%
Jan 25	7.47%
Jan 25	6.94%
Jan 25	7.95%
Dec 24	7.02%
Dec 24	7.15%
Dec 24	7.31%
Dec 24	7.24%
Nov 24	7.29%
Nov 24	7.04%
Nov 24	7.14%
Nov 24	6.9%
Nov 24	6.64%
Oct 24	6.97%
Oct 24	6.55%

Price to Sales

APNHY Price to Sales by quarter
Period	Price to Sales
Sep 26	0.84
Sep 26	0.79
Aug 26	0.76
Aug 26	0.75
Aug 26	0.81
Aug 26	0.81
Jul 26	0.78
Jul 26	0.81
Jul 26	0.8
Jul 26	0.78
Jul 26	0.82
Jun 26	0.81
Jun 26	0.76
Jun 26	0.76
Jun 26	0.78
May 26	0.76
May 26	0.72
May 26	0.79
May 26	0.77
May 26	0.71
Apr 26	0.75
Apr 26	0.7
Apr 26	0.73
Apr 26	0.69
Mar 26	0.66
Mar 26	0.68
Mar 26	0.67
Mar 26	0.7
Feb 26	0.67
Feb 26	0.65
Feb 26	0.62
Feb 26	0.54
Jan 26	0.55
Jan 26	0.57
Jan 26	0.61
Jan 26	0.59
Jan 26	0.55
Dec 25	0.47
Dec 25	0.48
Dec 25	0.47
Dec 25	0.47
Nov 25	0.46
Nov 25	0.47
Nov 25	0.48
Nov 25	0.49
Oct 25	0.48
Oct 25	0.5
Oct 25	0.51
Oct 25	0.5
Oct 25	0.49
Sep 25	0.48
Sep 25	0.51
Sep 25	0.53
Sep 25	0.52
Aug 25	0.53
Aug 25	0.52
Aug 25	0.56
Aug 25	0.55
Aug 25	0.58
Jul 25	0.6
Jul 25	0.57
Jul 25	0.58
Jul 25	0.62
Jun 25	0.6
Jun 25	0.6
Jun 25	0.6
Jun 25	0.61
May 25	0.62
May 25	0.59
May 25	0.6
May 25	0.62
May 25	0.62
Apr 25	0.6
Apr 25	0.8
Apr 25	0.74
Apr 25	0.74
Mar 25	0.86
Mar 25	0.94
Mar 25	0.93
Mar 25	0.91
Feb 25	0.88
Feb 25	0.89
Feb 25	0.89
Feb 25	0.88
Jan 25	0.88
Jan 25	0.87
Jan 25	0.85
Jan 25	0.92
Jan 25	0.8
Dec 24	0.91
Dec 24	0.89
Dec 24	0.87
Dec 24	0.88
Nov 24	0.88
Nov 24	0.91
Nov 24	0.89
Nov 24	0.92
Nov 24	0.96
Oct 24	0.91
Oct 24	0.97

EV/EBITDA

APNHY EV/EBITDA by quarter
Period	EV/EBITDA
Sep 26	7.82
Sep 26	7.47
Aug 26	7.3
Aug 26	7.25
Aug 26	7.66
Aug 26	7.64
Jul 26	7.46
Jul 26	7.67
Jul 26	7.55
Jul 26	7.45
Jul 26	7.68
Jun 26	7.63
Jun 26	7.33
Jun 26	7.28
Jun 26	7.45
May 26	7.3
May 26	7
May 26	7.47
May 26	7.37
May 26	6.99
Apr 26	7.22
Apr 26	6.87
Apr 26	7.08
Apr 26	6.83
Mar 26	6.75
Mar 26	6.88
Mar 26	6.86
Mar 26	7.06
Feb 26	6.85
Feb 26	6.67
Feb 26	6.52
Feb 26	5.99
Jan 26	6.02
Jan 26	6.13
Jan 26	6.41
Jan 26	6.29
Jan 26	6
Dec 25	5.48
Dec 25	5.55
Dec 25	5.49
Dec 25	5.5
Nov 25	5.44
Nov 25	5.45
Nov 25	5.52
Nov 25	5.62
Oct 25	5.55
Oct 25	5.7
Oct 25	5.72
Oct 25	5.7
Oct 25	5.6
Sep 25	3.42
Sep 25	3.55
Sep 25	3.66
Sep 25	3.63
Aug 25	3.67
Aug 25	3.61
Aug 25	3.79
Aug 25	3.74
Aug 25	3.86
Jul 25	3.93
Jul 25	3.82
Jul 25	3.88
Jul 25	4.02
Jun 25	3.94
Jun 25	3.96
Jun 25	3.95
Jun 25	4.01
May 25	4.03
May 25	3.91
May 25	3.93
May 25	4.02
May 25	4.05
Apr 25	3.94
Apr 25	4.8
Apr 25	4.55
Apr 25	4.54
Mar 25	4.77
Mar 25	5.09
Mar 25	5.04
Mar 25	4.99
Feb 25	4.86
Feb 25	4.88
Feb 25	4.87
Feb 25	4.84
Jan 25	4.85
Jan 25	4.79
Jan 25	4.73
Jan 25	5.01
Jan 25	4.52
Dec 24	4.97
Dec 24	4.89
Dec 24	4.82
Dec 24	4.85
Nov 24	4.82
Nov 24	4.96
Nov 24	4.9
Nov 24	5.03
Nov 24	5.18
Oct 24	4.99
Oct 24	5.24

Price/Operating Cashflow

APNHY Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Sep 26	5.65
Sep 26	5.3
Aug 26	5.13
Aug 26	5.08
Aug 26	5.49
Aug 26	5.47
Jul 26	5.29
Jul 26	5.5
Jul 26	5.38
Jul 26	5.28
Jul 26	5.51
Jun 26	5.46
Jun 26	5.16
Jun 26	5.11
Jun 26	5.28
May 26	5.13
May 26	4.83
May 26	5.3
May 26	5.2
May 26	4.82
Apr 26	5.04
Apr 26	4.7
Apr 26	4.91
Apr 26	4.65
Mar 26	5.09
Mar 26	5.24
Mar 26	5.22
Mar 26	5.43
Feb 26	5.2
Feb 26	5
Feb 26	4.82
Feb 26	4.22
Jan 26	4.26
Jan 26	4.38
Jan 26	4.7
Jan 26	4.56
Jan 26	4.23
Dec 25	3.64
Dec 25	3.72
Dec 25	3.65
Dec 25	3.66
Nov 25	3.59
Nov 25	3.6
Nov 25	3.68
Nov 25	3.8
Oct 25	3.72
Oct 25	3.89
Oct 25	3.91
Oct 25	3.89
Oct 25	3.78
Sep 25	3.54
Sep 25	3.78
Sep 25	3.96
Sep 25	3.91
Aug 25	3.98
Aug 25	3.88
Aug 25	4.2
Aug 25	4.11
Aug 25	4.31
Jul 25	4.44
Jul 25	4.25
Jul 25	4.34
Jul 25	4.59
Jun 25	4.46
Jun 25	4.49
Jun 25	4.47
Jun 25	4.58
May 25	4.61
May 25	4.41
May 25	4.44
May 25	4.6
May 25	4.65
Apr 25	4.46
Apr 25	5.95
Apr 25	5.51
Apr 25	5.5
Mar 25	6.27
Mar 25	6.83
Mar 25	6.74
Mar 25	6.65
Feb 25	6.43
Feb 25	6.47
Feb 25	6.44
Feb 25	6.39
Jan 25	6.4
Jan 25	6.3
Jan 25	6.21
Jan 25	6.68
Jan 25	5.83
Dec 24	6.61
Dec 24	6.48
Dec 24	6.35
Dec 24	6.4
Nov 24	6.36
Nov 24	6.59
Nov 24	6.5
Nov 24	6.72
Nov 24	6.99
Oct 24	6.65
Oct 24	7.08

Price to Book

APNHY Price to Book by quarter
Period	Price to Book
Sep 26	0.86
Sep 26	0.81
Aug 26	0.78
Aug 26	0.77
Aug 26	0.84
Aug 26	0.83
Jul 26	0.81
Jul 26	0.84
Jul 26	0.82
Jul 26	0.8
Jul 26	0.84
Jun 26	0.83
Jun 26	0.79
Jun 26	0.78
Jun 26	0.8
May 26	0.78
May 26	0.74
May 26	0.81
May 26	0.79
May 26	0.73
Apr 26	0.77
Apr 26	0.72
Apr 26	0.75
Apr 26	0.71
Mar 26	0.68
Mar 26	0.7
Mar 26	0.7
Mar 26	0.73
Feb 26	0.7
Feb 26	0.67
Feb 26	0.65
Feb 26	0.57
Jan 26	0.57
Jan 26	0.59
Jan 26	0.63
Jan 26	0.61
Jan 26	0.57
Dec 25	0.49
Dec 25	0.5
Dec 25	0.49
Dec 25	0.49
Nov 25	0.48
Nov 25	0.48
Nov 25	0.49
Nov 25	0.51
Oct 25	0.5
Oct 25	0.52
Oct 25	0.52
Oct 25	0.52
Oct 25	0.51
Sep 25	0.49
Sep 25	0.53
Sep 25	0.55
Sep 25	0.54
Aug 25	0.55
Aug 25	0.54
Aug 25	0.58
Aug 25	0.57
Aug 25	0.6
Jul 25	0.62
Jul 25	0.59
Jul 25	0.6
Jul 25	0.64
Jun 25	0.62
Jun 25	0.62
Jun 25	0.62
Jun 25	0.64
May 25	0.64
May 25	0.61
May 25	0.62
May 25	0.64
May 25	0.65
Apr 25	0.62
Apr 25	0.83
Apr 25	0.77
Apr 25	0.77
Mar 25	0.87
Mar 25	0.95
Mar 25	0.93
Mar 25	0.92
Feb 25	0.89
Feb 25	0.9
Feb 25	0.89
Feb 25	0.88
Jan 25	0.89
Jan 25	0.87
Jan 25	0.86
Jan 25	0.92
Jan 25	0.81
Dec 24	0.91
Dec 24	0.9
Dec 24	0.88
Dec 24	0.89
Nov 24	0.88
Nov 24	0.91
Nov 24	0.9
Nov 24	0.93
Nov 24	0.97
Oct 24	0.92
Oct 24	0.98

No video analysis for this stock yet. Request one from our team.

News: APNHY

zacks.com · 10 Sep 2026

Is Aspen Pharmacare (APNHY) Outperforming Other Medical Stocks This Year?

Here is how Aspen Pharmacare (APNHY) and Cardiol Therapeutics Inc. (CRDL) have performed compared to their sector so far this year.

reuters.com · 3 Sep 2026

Aspen sees Mounjaro Africa sales above $124 million in 2027

Aspen Pharmacare expects African sales ‌of Eli Lilly's blockbuster weight-loss and diabetes drug Mounjaro to exceed 2 billion rand ($124 million) in its current financial year, buoyed by surging demand in South Africa and planned launches in Nigeria and Kenya.

seekingalpha.com · 3 Sep 2026

AI Analysis

Aspen Pharmacare Holdings Limited

Video analysis: APNHY

News: APNHY

Is Aspen Pharmacare (APNHY) Outperforming Other Medical Stocks This Year?

Aspen sees Mounjaro Africa sales above $124 million in 2027

Aspen Pharmacare Holdings Limited (APNHY) Q4 2026 Earnings Call Transcript

Similar companies